Understand the differences
Transplant Care Pathways
Choose the pathway that matches your enquiry and learn what only a licensed transplant hospital can decide.
Pathway navigator
Start with the type of care being considered.
Each page explains the pathway category, what a hospital may evaluate, and the questions that protect patients and donors.
01Kidney transplant: evaluation, donor pathways and safetyA patient-focused guide to kidney transplant evaluation, donor pathways, preparation and the questions to ask before pursuing care abroad.Living-donor and deceased-donor pathways02Liver transplant navigationAn independent overview of living-donor and deceased-donor liver pathways and the questions to take to a licensed transplant hospital.Living-donor and deceased-donor pathways03Bone marrow and stem cell transplant: types and evaluationA practical guide to bone marrow and haematopoietic stem cell transplant types, evaluation, donor matching and preparation for specialist review.Autologous and allogeneic HSCT pathways04Pediatric bone marrow transplant navigationA child-focused overview of case-specific HSCT assessment without assuming that a diagnosis automatically requires transplant.Specialist pediatric autologous and allogeneic evaluation05CAR-T Cell Therapy navigationA clinically bounded guide to specialist CAR-T Cell Therapy review without promises about eligibility, product availability, timing, price or outcome.Selected relapsed or refractory hematologic malignancies06Corneal transplant navigationAn introduction to corneal tissue pathways, hospital evaluation, and the need for regulated tissue handling.Donated tissue pathway07Heart transplant navigationA safety-first explanation of hospital evaluation and deceased-donor allocation without promises of access or priority.Deceased-donor allocation pathway08Lung transplant navigationA concise guide to the regulated deceased-donor pathway and questions for specialist hospitals.Deceased-donor allocation pathway09Pancreas transplant navigationAn overview of specialist assessment and allocation constraints for pancreas and combined kidney-pancreas pathways.Deceased-donor allocation pathway10Other lawful transplant pathwaysA navigation framework for less common pathways that requires specialist, jurisdiction-specific verification.Specialist and jurisdiction-specific pathways
| Pathway | Source | Decision authority | Critical safeguard |
|---|---|---|---|
| Living donor | A medically suitable person | Licensed transplant hospital and applicable authorities | Independent donor assessment and voluntary consent |
| Deceased donor | Authorized donation system | National or regional allocation system | Equitable, lawful allocation without purchased priority |
| Tissue and cornea | Regulated tissue donation and banking | Qualified clinical programme | Traceability, processing standards, and follow-up |
| Stem cell | Patient or matched donor, depending on pathway | Specialist transplant programme | Evidence-based indication, matching, and donor safety |
Patient safety
Navigation with firm boundaries
MedTransplant provides independent education and navigation. We do not source organs or donors, influence allocation, or promise clinical acceptance.
Licensed transplant hospitals make all clinical decisions, and national laws always apply.
